Cleared Traditional

K090943 - ABT GLUCOSE CONTROL SOLUTION, MODEL: 2120089

K090943 is an FDA 510(k) clearance for ABT GLUCOSE CONTROL SOLUTION, manufactured by American Biological Technologies, Inc.. The device is a Class 1 Chemistry device with product code JJX cleared through the Traditional 510(k) pathway after a 54-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2009
Decision
54d
Days
Class 1
Risk

K090943 is an FDA 510(k) clearance for the ABT GLUCOSE CONTROL SOLUTION, MODEL: 2120089. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by American Biological Technologies, Inc. (Seguin, US). The FDA issued a Cleared decision on May 27, 2009 after a review of 54 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all American Biological Technologies, Inc. devices

FDA 510(k) Submission Details - K090943

510(k) Number K090943 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 03, 2009
Decision Date May 27, 2009
Days to Decision 54 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 88d · This submission: 54d
Pathway characteristics
Predicate-based equivalence.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 426
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K090943.
LIAISON 25 OH VITAMIN D TOTAL CALIBRATION VERIFIERS, MODEL: 310603
K090104 · DiaSorin, Inc. · Sep 2009
FDI GLUCOSE CONTROL LEVELS 1, 2 AND 3
K092645 · Fujirebio Diagnostics,Inc. · Sep 2009
ADVIA CENTAUR DHEAS MASTER CURVE MATERIALS
K091123 · Siemens Healthcare Diagnostics · Aug 2009
ELECSYS RUBELLA IGG CALCHECK
K090311 · Roche Diagnostics · May 2009
ELECSYS TOXO IGG CALCHECK
K083655 · Roche Diagnostics · Feb 2009
RNA MEDICAL GLUCOSE AND B-KETONE CALIBRATION VERIFICATION CONTROLS
K081478 · Bionostics, Inc. · Oct 2008